All China Stocks -All Information About China Stocks Traded In U.S. Stock Markets

AllChinaStocks

Biostar Pharmaceuticals, Inc. (BSPM), 2017-05-24 4:37:54 PM

 

1.65 -0.02 (-1.20%)

5/24/2017  3:58pm

Open:

1.64

Pre close:

1.67

High:

1.65

Low:

1.62

Volume:

5,261

Market Cap:

4.35M

Overall  

    ***   

What's this
Target Six months: 2.14     One year: 2.34
Support Support1: 1.57    Support2: 1.31
Resistance Resistance1: 1.84    Resistance2: 2.00 
Pivot 1.68 
Moving Averages

MA(5): 1.67     MA(20): 1.69

MA(100): 2.35     MA(250): 3.06

MACD MACD(12,26): -0.08     Signal(12,26,9): -0.10
Stochastic Oscillator %K(14,3): 29.97     %D(3): 31.67
RSI RSI(14): 38.93

Financials: 

EPS

-2.500

EPS Est. Current Year

0.600

EPS Est. Next Quarter

EPS Est. Next Year

Forward EPS

Book Value (p.s.)

13.980

PEG Ratio

Profit Margin

-238.98

Operating Margin

-149.48

Return on Assets (ttm)

-4.8

Return on Equity (ttm)

-14.1

Qtrly Rev. Growth

-82.7

Gross Profit (p.s.)

0.347

Sales Per Share

0.902

EBITDA (p.s.)

-0.917

Qtrly Earnings Growth

Operating Cash Flow (M)

4.91

Levered Free Cash Flow (M)

6.69

Statistics

Shares Out. (M)

Shares Float (M)

2.19

% Held by Insiders

% Held by Institutions

Shares Short (K)

322

SharesShort PriorMonth (K)

313

Valuation

P/E

-0.66

P/E Growth Ratio

-0.01

P/BV

0.12

P/S

1.83

P/CF

Dividend Yield

Stock Price History

52-Week High

7.06

52-Week Change (%)

52-Week Low

1.17

32.0

* Strong Sell ** Sell *** Neutral **** Buy ***** Strong Buy

 

Symbol:

BSPM

Company Name:

Biostar Pharmaceuticals, Inc.

IPO Year:

n/a

Sector

Health Care

Industry:

Major Pharmaceuticals

Headline News

Fri, 19 May 2017 20:30:00 +0000

Biostar Pharmaceuticals, Inc. Announces Its Quarterly Results for Three Months Ended March 31, 2017

XIANYANG, China, May 19, 2017 /PRNewswire/ - Biostar Pharmaceuticals, Inc. (NASDAQ: BSPM) ("Biostar" or "the Company"), a PRC-based manufacturer and marketer of pharmaceutical and health ...

Thu, 13 Apr 2017 20:00:00 +0000

Biostar Pharmaceuticals, Inc. Announces Its Annual Results for The Year Ended December 31, 2016

XIANYANG, China, April 13, 2017 /PRNewswire/ - Biostar Pharmaceuticals, Inc. (NASDAQ: BSPM) ("Biostar" or "the Company"), a PRC-based manufacturer and marketer of pharmaceutical and ...

Mon, 21 Nov 2016 21:30:00 +0000

Biostar Pharmaceuticals, Inc. Announces Its Quarterly Results for Three Months Ended September 30, 2016

XIANYANG, China, Nov. 21, 2016 /PRNewswire/ -- Biostar Pharmaceuticals, Inc. (NASDAQ: BSPM) ("Biostar" or "the Company"), a PRC-based manufacturer and marketer of pharmaceutical and ...

Tue, 18 Oct 2016 20:30:00 +0000

Biostar Pharmaceuticals Completes Previously Announced Registered Direct Financing

XIANYANG, China, Oct. 18, 2016 /PRNewswire/ -- Biostar Pharmaceuticals, Inc. (BSPM) ("Biostar"), a PRC-based manufacturer and marketer of pharmaceutical and health supplement products in China, announced today that it completed the sale of 425,000 shares of common stock at the price of $4.50 per share, and warrants to purchase 212,500 shares of common stock to institutional investors for gross proceeds of approximately $1.91 million. Biostar plans to use the net proceeds of this offering for working capital and general corporate purposes. A prospectus supplement relating to the offering has been filed by Biostar with the SEC.

Wed, 12 Oct 2016 13:18:00 +0000

Biostar Announces Execution of Agreement for $1.91 Million Registered Direct Offering of Shares of Common Stock and Warrants

XIANYANG, China, Oct. 12, 2016 /PRNewswire/ -- Biostar Pharmaceuticals, Inc. (BSPM) ("Biostar" or "the Company"), a PRC-based manufacturer and marketer of pharmaceutical and health supplement products in China, announced today that it entered into a securities purchase agreement (the "Securities Purchase Agreement") with certain institutional investors for the sale of 425,000 shares of common stock in a registered direct offering at the price of $4.50 per share. Gross proceeds of the offering, before deducting placement agent fees and other estimated offering expenses payable by the Company, are expected to be approximately $1.91 million.  The net proceeds from this offering will be used for working capital and other general corporate purposes. The securities are being offered through a prospectus supplement pursuant to the Company's effective shelf registration statement and base prospectus.

All China Stocks -All Information About China Stocks Traded In U.S. Stock Markets

All China Stocks dedicates to providing information about China stocks traded in U.S. stock markets, includes: markets headline news, Chinese stocks headline news, Chinese stocks to watch, Chinese stock real time quotes, Chinese stock company profiles and annual reports, objective Chinese stock research and analysis.

©2006 AllChinaStocks.com  Home  Stock Quotes  Stock Picks  Stock Symbols  Allindianstocks  Stoxline  Contact us